Akamai estimates about US$5.5B in capex tied to its US$11.6B Anthropic deal; first services are planned for late second ...

The FDA expanded Olumiant to severe alopecia areata patients 12 and older after a trial showed 42 per cent response on 4 mg.

WISeKey expects its merger into WISeQey on Oct. 2, with ordinary shares due to start Nasdaq and SIX trading on Oct. 5.

Nanexa closed Sept. 25 at SEK 12.16 after a Novo Nordisk licence worth up to €1.165B in upfront and conditional payments.

Rexel plans about €800M in cash and debt and a possible €500M equity sale to fund its GCG acquisition, targeted to close by ...

Bonza Sur hole BLP-2026-553 cut 3.05 metres at 204.26 grams per tonne gold, while Quebrada Dorada extended the trend beyond ...

Merck and Daiichi Sankyo withdrew the ifinatamab BLA on Sept. 25 after FDA discussions; the Oct. 10 action date had been set.

Cresco Labs is asking holders to approve three changes on Oct. 30, including a share exchange and a possible move to Delaware ...

NRC staff found PG&E's Diablo Canyon Unit 1 capsule report met federal rules on Sept. 24; the plant's licences were renewed ...

Six of 10 higher-dose ALTITUDE participants improved by more than two DRSS steps at three years; NAAVIGATE is testing the ...